Understanding how specific proteins regulate mRNA degradation in blood cell development
The DF phospho-code regulating the degradation of m6A mRNA
This study is looking at how a specific change in proteins affects the breakdown of important messages in our cells that help blood stem cells turn into different types of blood cells, which could help us understand blood cell development better and find new ways to treat related health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10911133 on NIH RePORTER |
What this research studies
This research investigates the role of a specific protein modification, known as phosphorylation, in the degradation of m6A-modified mRNAs, which are crucial for the differentiation of blood stem cells. The study aims to identify how these modifications influence the stability of mRNAs and the commitment of hematopoietic stem cells to develop into various blood cell types. By mapping the phosphorylation patterns of the YTHDF proteins, the research seeks to uncover the mechanisms that control mRNA degradation during blood cell differentiation. This could lead to a better understanding of blood cell development and potential therapeutic targets for related disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with hematological conditions or those interested in blood cell development.
Not a fit: Patients with conditions unrelated to blood cell differentiation may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights into new treatments for blood disorders by targeting the mechanisms of blood cell differentiation.
How similar studies have performed: Other research has shown promising results in understanding mRNA regulation through similar protein modification approaches, indicating potential for success in this area.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Zaccara, Sara — Columbia University Health Sciences
- Study coordinator: Zaccara, Sara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.